TrumpRx prices for brand-name drugs are about as likely to be higher as lower compared to average prices in other wealthy countries, according to an analysis that compares 32 brand-name drugs (without generics or biosimilars) on the TrumpRx website with publicly available prices in one or more of 11 OECD member countries.
Consumers who buy brand-name prescription drugs without an available generic or biosimilar at the prices available through the new TrumpRx website are about as likely to pay more as pay less for those drugs relative to the publicly listed prices available in other comparatively wealthy countries, a new KFF analysis finds.
Many reproductive-age women seek health information through online sources, where they may encounter false or misleading information about contraception, according to the 2026 KFF Women’s Health Survey. And an Ohio health department’s new AI policy offers a rare example of a health-specific policy addressing accuracy and public trust.
As health care costs dominate the national political conversation, our 2026 KFF Women’s Health Survey shows the toll those costs are taking on women. Our new nationally representative survey of women and men ages 18–64 finds costs remain a major barrier for women, specifically — causing everything from delayed care to rationed medications to cuts…
Rural voters’ frustrations about the cost of living in their community are growing and appear to be chipping away at Republicans’ enthusiasm to vote as the midterm elections near, a new KFF/AP Survey of Rural Voters finds.
The KFF/AP Rural Voters Survey examines the views and political priorities of voters living in rural areas across the United States ahead of the 2026 midterm elections. The survey gauges rural voters’ top election issues, growing struggles with cost of living and health care costs, as well as views on the Trump administration’s health care…
The 2025 reconciliation law includes new eligibility restrictions for many lawfully present immigrants for Medicaid and CHIP that become effective October 1, 2026. This brief provides an overview of implementation of the immigrant eligibility changes based on CMS guidance and issues to consider for affected individuals and states.
Across the tech industry, many of AI’s own leaders are calling for oversight — self-imposed or from government. That debate is on, but where it will land is anyone’s guess. Joe Grogan takes a different tack: the biggest threat in health care AI may not be too little regulation, but the wrong kind.
This policy watch examines recent and anticipated managed care rate setting challenges and the potential implications of MCO exits.
As of 2024, approximately 28.5 million people in the United States ages five and older have limited English proficiency (LEP). Individuals with LEP disproportionately experience gaps in health insurance coverage and poor health outcomes, in part, due to language access barriers. Because people of color are more likely than White people to have LEP, these…